{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:46:18Z","timestamp":1788482778746,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bmcl.2020.127615","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T11:11:15Z","timestamp":1602933075000},"page":"127615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of DHQ-based chemical biology probe to profile cellular targets for HBV"],"prefix":"10.1016","volume":"30","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Yee","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Man Eva","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5465-7727","authenticated-orcid":false,"given":"Xuechen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127615_b0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2018.07.019","article-title":"Hepatitis B virus: the challenge of an ancient virus with multiple faces and a remarkable replication strategy","volume":"158","author":"Caballero","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.127615_b0010","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1093\/infdis\/jix355","article-title":"Toward a cure for hepatitis B virus infection: combination therapy involving viral suppression and immune modulation and long-term outcome","volume":"216","author":"Wu","year":"2017","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.bmcl.2020.127615_b0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/acsinfecdis.7b00144","article-title":"Discovery of small molecule therapeutics for treatment of chronic HBV infection","volume":"4","author":"Feng","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"12","key":"10.1016\/j.bmcl.2020.127615_b0020","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/AAC.00541-07","article-title":"A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion","volume":"51","author":"Dougherty","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2020.127615_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2014.04.002","article-title":"Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion","volume":"107","author":"Xu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2020.127615_b0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2015.06.030","article-title":"Design, synthesis, and biological evaluation of new N 4 -Substituted 2\u2032-deoxy-2\u2032-fluoro-4\u2032-azido cytidine derivatives as potent anti-HBV agents","volume":"101","author":"Lv","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127615_b0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3851\/IMP2094","article-title":"Antiviral activity of FNC, 2'-deoxy-2'-beta-fluoro-4'-azidocytidine, against human and duck HBV replication","volume":"17","author":"Zheng","year":"2012","journal-title":"Antivir Ther"},{"issue":"8","key":"10.1016\/j.bmcl.2020.127615_b0040","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3851\/IMP2292","article-title":"Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant hepatitis B virus clinical isolates","volume":"17","author":"Zhou","year":"2012","journal-title":"Antivir Ther"},{"issue":"23","key":"10.1016\/j.bmcl.2020.127615_b0045","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/acs.jmedchem.8b01245","article-title":"Discovery of RG7834: the first-in-class selective and orally available small molecule hepatitis B virus expression inhibitor with novel mechanism of action","volume":"61","author":"Han","year":"2018","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2020.127615_b0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.bmcl.2020.127615_b0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2017.11.009","article-title":"HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element","volume":"149","author":"Zhou","year":"2018","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.bmcl.2020.127615_b0060","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.30329","article-title":"PAPD5\/7 are host factors that are required for hepatitis B virus RNA stabilization","volume":"69","author":"Mueller","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bmcl.2020.127615_b0065","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.celrep.2019.10.113","article-title":"A genome-wide CRISPR screen identifies ZCCHC14 as a host factor required for hepatitis B surface antigen production","volume":"29","author":"Hyrina","year":"2019","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127615_b0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: from enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/j.bmcl.2020.127615_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1039\/C3MD00276D","article-title":"Affinity-based target identification for bioactive small molecules","volume":"5","author":"Kawatani","year":"2014","journal-title":"Med Chem Commun"},{"issue":"5","key":"10.1016\/j.bmcl.2020.127615_b0080","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/C6NP00001K","article-title":"Chemical proteomics approaches for identifying the cellular targets of natural products","volume":"33","author":"Wright","year":"2016","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmcl.2020.127615_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pharmthera.2016.01.010","article-title":"Target identification of natural and traditional medicines with quantitative chemical proteomics approaches","volume":"162","author":"Wang","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2020.127615_b0090","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1002\/anie.201914257","article-title":"Biomimetic synthesis of rhytidenone A and mode of action of cytotoxic rhytidenone F","volume":"59","author":"Yue","year":"2020","journal-title":"Angew Chem Int Ed"},{"issue":"6","key":"10.1016\/j.bmcl.2020.127615_b0095","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1021\/acs.analchem.9b05327","article-title":"Molecular imaging and in situ quantitative profiling of fatty acid synthase with a chemical probe","volume":"92","author":"Xu","year":"2020","journal-title":"Anal Chem"},{"issue":"41","key":"10.1016\/j.bmcl.2020.127615_b0100","doi-asserted-by":"crossref","first-page":"39851","DOI":"10.1074\/jbc.M301618200","article-title":"Antisense oligodeoxynucleotides targeted against molecular chaperonin hsp60 block human hepatitis B virus replication","volume":"278","author":"Park","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127615_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/viro.2002.1496","article-title":"Binding site analysis of human HBV pol for molecular chaperonin, Hsp60","volume":"298","author":"Park","year":"2002","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.bmcl.2020.127615_b0110","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00705-005-0521-1","article-title":"HBx protein of hepatitis B virus (HBV) can form complex with mitochondrial HSP60 and HSP70","volume":"150","author":"Zhang","year":"2005","journal-title":"Arch Virol"},{"issue":"15","key":"10.1016\/j.bmcl.2020.127615_b0115","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/JVI.75.15.6962-6968.2001","article-title":"Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60","volume":"75","author":"Park","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bmcl.2020.127615_b0120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2009.02.003","article-title":"Interaction of hepatitis C virus core protein with Hsp60 triggers the production of reactive oxygen species and enhances TNF-alpha-mediated apoptosis","volume":"279","author":"Kang","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bmcl.2020.127615_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12953-017-0114-4","article-title":"Proteomic profiling of HBV infected liver biopsies with different fibrotic stages","volume":"15","author":"Katrinli","year":"2016","journal-title":"Proteome Sci"},{"key":"10.1016\/j.bmcl.2020.127615_b0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12864-017-3984-z","article-title":"Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model","volume":"18","author":"Kan","year":"2017","journal-title":"BMC Genomics"},{"issue":"10","key":"10.1016\/j.bmcl.2020.127615_b0135","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pmic.200700849","article-title":"Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model","volume":"8","author":"Tong","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bmcl.2020.127615_b0140","series-title":"RNA binding proteins: new concepts in gene regulation","author":"Sandberg","year":"2013"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20307265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20307265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:40:04Z","timestamp":1760773204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20307265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0960894X20307265"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127615","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of DHQ-based chemical biology probe to profile cellular targets for HBV","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127615"}}